Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
Neuropathic pain is a debilitating clinical condition with few efficacious treatments, warranting development of novel therapeutics. We hypothesized that dysregulated translation regulation pathways may underlie neuropathic pain. Peripheral nerve injury induced reorganization of translation machiner...
Main Authors: | Melemedjian, Ohannes K, Asiedu, Marina N, Tillu, Dipti V, Sanoja, Raul, Yan, Jin, Lark, Arianna, Khoutorsky, Arkady, Johnson, Jessica, Peebles, Katherine A, Lepow, Talya, Sonenberg, Nahum, Dussor, Gregory, Price, Theodore J |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186752/ |
Similar Items
-
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain
by: Tillu, Dipti V, et al.
Published: (2012) -
Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity
by: Melemedjian, Ohannes K, et al.
Published: (2014) -
Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6)
by: Yan, Jin, et al.
Published: (2012) -
The potent, indirect adenosine monophosphate-activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice
by: Mejia, Galo L., et al.
Published: (2016) -
The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
by: Rundfeldt, Chris, et al.
Published: (2012)